Maja H Oktay

7PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMechanobiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 11, 2025
Targeting CSF-1 signaling between tumor cells and macrophages at TMEM doorways inhibits breast cancer dissemination.

Camille L Duran, Chinmay R Surve, Xianjun Ye

|Jan 27, 2025
Paclitaxel causes de novo induction of invasive breast cancer cells by repolarizing tumor-associated macrophages.

Madeline Friedman-DeLuca, George S Karagiannis, Camille L Duran

|Nov 12, 2024
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.

Jesus D Anampa, Daniel L Flynn, Cynthia Leary

|Oct 23, 2023
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.

Alexander Ferrena, Jichuan Wang, Ranxin Zhang

|Jun 13, 2023
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy.

Gina Kim, Burcu Karadal-Ferrena, Jiyue Qin

|Oct 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study.

Thomas E Rohan, Mindy Ginsberg, Yihong Wang

Pageof 2

Frequent Collaborators

5 joint publications

David Entenberg

4 joint publications

Joseph A Sparano

3 joint publications

John S Condeelis

2 joint publications

Camille L Duran